Immucor's mission has always been about finding the right match. With the same focus #SpecializedDiagnostics, Werfen and Immucor are the right match. The Immucor team is excited to join Werfen and contribute to #PoweringPatientCare.
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular matching and prediction analysis, announced a multi-year partnership to expand […]
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics announced two additions to its transplant diagnostics portfolio, demonstrating their ongoing commitment to new advancements in the field of histocompatibility. Immucor announced […]
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user experience without compromising best-in-class performance and accuracy! Currently, there are multiple Next Generation Sequencing (NGS) products and software available to histocompatibility and immunogenetic laboratories. Offering […]
Immucor is in the process of improving our LIFECODES® LifeScreen Deluxe (LMX) to add DP enhanced beads! LMX is a qualitative bead-based immunoassay used to detect IgG antibodies to HLA Class I and Class II molecules. Currently the assay has […]
For all histocompatibility laboratories, Complement-Dependent Cytotoxicity (CDC) testing proves to be time consuming and tedious when evaluating the efforts needed to QC reagents, prepare trays, and perform proficiency testing. Mid-South Transplant Foundation (MSTF) is a private, non-profit organ procurement organization […]